Key Financial Inc’s Bio-Rad Laboratories Class A BIO Stock Holding History

Key Financial Inc’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$294	Hold	1	–	–	﹤0.01%	1294
2026 Q1	$279	Hold	1	–	–	﹤0.01%	1335
2025 Q4	$303	Hold	1	–	–	﹤0.01%	1355
2025 Q3	$298	Hold	1	–	–	﹤0.01%	1374
2025 Q2	$241	Hold	1	–	–	﹤0.01%	1374
2025 Q1	$244	Hold	1	–	–	﹤0.01%	1333
2024 Q4	$329	Hold	1	–	–	﹤0.01%	1323
2024 Q3	$335	Hold	1	–	–	﹤0.01%	1292
2024 Q2	$273	Buy	+1	New	+$291	﹤0.01%	1287

Other funds holding BIO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Key Financial Inc's BIO Position: Q2 2026 in Review

Key Financial Inc held its Bio-Rad Laboratories Class A (BIO) position steady in Q2 2026 at 1 share worth $294. The position accounts for ﹤0.01% of the portfolio, ranked #1294.

Key Financial Inc first reported a position in BIO in Q2 2024 and has held it in 9 quarters since. The position peaked at $335 in Q3 2024. 398 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

Key Financial Inc held 1 share of Bio-Rad Laboratories Class A worth $294 as of Q2 2026.
Key Financial Inc left its Bio-Rad Laboratories Class A share count unchanged in Q2 2026.
Bio-Rad Laboratories Class A made up ﹤0.01% of Key Financial Inc's portfolio in Q2 2026, its #1294 holding.
Key Financial Inc first reported a position in Bio-Rad Laboratories Class A in Q2 2024 and has held it in 9 quarters since.
Key Financial Inc's Bio-Rad Laboratories Class A position peaked at $335 in Q3 2024.
398 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Key Financial Inc's 13F filing for Q2 2026, filed 24 Jul 2026.